Descrizione business
Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological, autoimmune and rare diseases. Founded in 1978, Biogen is one of the world’s oldest independent biotechnology companies and patients worldwide benefit from its leading multiple sclerosis and innovative hemophilia therapies.
Consiglio di amministrazione & Consiglio di sorveglianza
| CEO |
| Christopher A. Viehbacher |
| Consiglio di amministrazione |
| Michael McDonnell, Dr. Ginger Gregory, Rachid Izzar, Susan H. Alexander, Nicole Murphy, Priya Singhal |
| Consiglio di sorveglianza |
| Caroline Dorsa, Eric K. Rowinsky, Jesus B. Mantas, Maria C. Freire, Stephen A. Sherwin, William A. Hawkins, Susan Langer, Christopher A. Viehbacher |
Dati aziendali
| Name: |
Biogen Inc. |
| Indirizzo: |
225 Binney Street,Cambridge, Massachusetts 02142, USA |
| Telefono: |
+1 781-464-2000 |
| Fax: |
+1-617-679-2617 |
| E-mail: |
-
|
| Internet: |
www.biogen.com |
| Industria: |
Biotechnology |
| Settore: |
Biotechnology |
| Sub settore: |
Biotechnology |
| Fine dell'anno finanziario: |
31/12 |
| Flottante libero: |
72.20% |
| Data dell'IPO: |
- |
Rapporti con gli investitori
| Name: |
Karen Jewell |
| IR telefono: |
781-464-2442 |
| IR Fax: |
- |
| IR e-mail: |
IR@biogenidec.com
|
